Our Curious Amalgam

Toggle navigation
  • About
  • Hosts
  • Gallery
  • Episodes
  • ABA
  • Search

Category: Health Care & Pharmaceuticals

Zack Cooper, Ph.D., Associate Professor of Public Health and Associate Professor of Economics, Yale University

#371 Who Does Your Doctor Work For? Vertical Integration in the Healthcare Provider Market

Posted 7 months ago Tagged antitrust economics healthcare vertical integration

Hospitals, as well as insurers, have been increasingly purchasing physicians practices, home health providers, and […]

https://ourcuriousamalgam.com/episode-player/3762/371-vertical-integration-healthcare-provider-market.mp3?stats-code=ocaPodcastSite
Dr. Paul Eliason, Assistant Professor of Economics, Brigham Young University

#336 What Are the Risks of Serial Acquisitions? Empirical Evidence From the Dialysis Industry

Posted 1 year ago Tagged

There is a growing interest in understanding the economics of serial acquisitions, particularly in the […]

https://ourcuriousamalgam.com/episode-player/3472/336-serial-acquisitions-dialysis-industry.mp3?stats-code=ocaPodcastSite
David Schwartz, Partner, Bryan Cave Leighton Paisner

#313 Who’s Blocking Me? Competition Law Issues With Healthcare Information Blocking

Posted 2 years ago Tagged healthcare information exchange interoperability

When it comes to your health, having digitized information available for seamless sharing across multiple […]

https://ourcuriousamalgam.com/episode-player/3340/313-healthcare-information-blocking.mp3?stats-code=ocaPodcastSite
Cory Capps, Partner, Bates White Economic Consulting

#285 Is It All Connected? Exploring Cross-Market Theories of Harm in Healthcare Mergers

Posted 2 years ago Tagged cross market theories FTC hospital mergers

Federal and State antitrust authorities have started to take closer looks into mergers of hospitals […]

https://ourcuriousamalgam.com/episode-player/3118/285-cross-market-healthcare-mergers.mp3?stats-code=ocaPodcastSite
Penka Kovacheva, Vice President, Cornerstone Research

#284 How Do We Measure Innovation? The Economic Analysis of the Impact of M&A on Innovation in the Pharmaceutical Industry

Posted 2 years ago Tagged health care innovation merger analysis merger guidelines pharmaceutical markets

When analyzing the competitive effects of a proposed transaction, the U.S. antitrust agencies may attempt […]

https://ourcuriousamalgam.com/episode-player/3115/284-innovation-pharmaceutical-industry.mp3?stats-code=ocaPodcastSite
Mika Ikeda, Senior Counsel, Competition Law, Johnson & Johnson

#257 Throwing the Book at Orange Book Listings? The FTC’s Views on the Antitrust Implications of Listing Patents in the Orange Book

Posted 3 years ago Tagged FDA generic drugs Orange Book patents Section 5

The interplay between patent law and competition law has been a consistent focus for the […]

https://ourcuriousamalgam.com/episode-player/2930/257-orange-book-patent-listings.mp3?stats-code=ocaPodcastSite
Casey Mulligan, Professor of Economics, University of Chicago

#241 Are PBMs Good For Competition? A Cost-Benefit Analysis of the Effects of Regulating Pharmacy Benefit Managers

Posted 3 years ago Tagged drug prices health care PBMs pharmacy benefit managers

Pharmacy benefit managers (PBMs) are being called out for engaging in allegedly anticompetitive business practices […]

https://ourcuriousamalgam.com/episode-player/2820/241-pharmacy-benefit-managers.mp3?stats-code=ocaPodcastSite
Theodosia Stavroulaki, Assistant Professor of Law, Gonzaga University School of Law

#240 Can Competition and Quality Coincide? Analyzing a Systematic Competition Law Approach to Healthcare and Quality Concerns

Posted 3 years ago Tagged health equity healthcare mergers quality of care

The role of antitrust in health care is a common topic in the antitrust world. […]

https://ourcuriousamalgam.com/episode-player/2816/240-healthcare-quality-competition.mp3?stats-code=ocaPodcastSite
Dr. Erin Trish, Co-Director, Schaeffer Center for Health Policy & Economics, University of Southern California

#212 A Sickness or a Cure for High Drug Prices? Why PBMs Are Under the Antitrust Microscope

Posted 4 years ago Tagged drug prices FTC insulin PBMs pharmacies pharmacy benefit managers

Drug prices are top of mind for numerous patients, legislators, policy experts, and antitrust enforcers […]

https://ourcuriousamalgam.com/episode-player/2622/212-high-drug-prices-pbm.mp3?stats-code=ocaPodcastSite
John Carroll, Partner, Sheppard Mullin

#193 Healthy Competition? Ten Years in Review of Antitrust and the Health Care Industry.

Posted 4 years ago Tagged ACA handbook healthcare managed care

The U.S. health care industry is complex and dynamic, resulting in antitrust issues that are […]

https://ourcuriousamalgam.com/episode-player/2446/193-ten-year-review-antitrust-health-care-industry.mp3?stats-code=ocaPodcastSite
Page 1 Page 2 Next
Subscribe
Listen on Apple Podcasts
Spotify
Amazon music
Audible
YouTube Music
Browse by category
Scroll to the top

Don't miss new episodes every Monday. Subscribe now!

Our Curious Amalgam explores topics in antitrust, competition, consumer protection, data protection, and privacy law around the world with leading experts in those areas. It is an amalgam because it is a group of diverse topics all in one place. It is curious because it gets the experts and asks them in-depth questions.

© 2019-2026 American Bar Association. All Rights Reserved.

NEWS AND EVENTS
What's Going on at the Antitrust Law Section

CONTACT US
podcast@ourcuriousamalgam.com

Find us on social!

Facebook Twitter Instagram LinkedIn RSS Feed

Subscribe
Listen on Apple Podcasts
Listen on Spotify
Amazon music
Audible
YouTube Music
The opinions expressed by the participants in the podcasts are their own and do not necessarily represent those of their employers or other affiliated organizations.